ProfileGDS4718 / 223538_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 94% 91% 95% 85% 96% 94% 97% 95% 96% 96% 93% 93% 95% 93% 92% 95% 93% 94% 92% 96% 95% 96% 95% 91% 94% 93% 96% 96% 93% 92% 92% 94% 97% 94% 95% 93% 94% 93% 91% 96% 94% 93% 95% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.489395
GSM549102patient 115, normal, homogenized [OPG study]10.023794
GSM549104patient 119, normal, homogenized [OPG study]9.4802491
GSM549108patient 138, normal, homogenized [OPG study]10.305695
GSM549119patient 077, normal, homogenized [OPG study]8.440285
GSM549133patient 032, cancer, homogenized [OPG study]10.4896
GSM549139patient 042, cancer, homogenized [OPG study]9.8463494
GSM549099patient 107, normal, homogenized [OPG study]11.060697
GSM549109patient 139, normal, homogenized [OPG study]10.34195
GSM549110patient 046, normal, homogenized [OPG study]10.674296
GSM549114patient 063, normal, homogenized [OPG study]10.899596
GSM549122patient 082, normal, homogenized [OPG study]9.9047693
GSM549134patient 033, cancer, homogenized [OPG study]9.7221493
GSM549136patient 036, cancer, homogenized [OPG study]10.152595
GSM549140patient 044, cancer, homogenized [OPG study]9.8433593
GSM549111patient 047, normal, homogenized [OPG study]9.7508792
GSM549113patient 057, normal, homogenized [OPG study]10.517695
GSM549132patient 031, cancer, homogenized [OPG study]9.6525893
GSM549137patient 038, cancer, homogenized [OPG study]9.8060494
GSM549142patient 047, cancer, homogenized [OPG study]9.0114292
GSM549100patient 110, normal, homogenized [OPG study]10.556596
GSM549107patient 135, normal, homogenized [OPG study]10.347295
GSM549115patient 068, normal, homogenized [OPG study]10.743296
GSM549116patient 072, normal, homogenized [OPG study]10.353495
GSM549120patient 078, normal, homogenized [OPG study]9.4602191
GSM549131patient 030, cancer, homogenized [OPG study]10.094194
GSM549118patient 074, normal, homogenized [OPG study]9.8274393
GSM549129patient 027, cancer, homogenized [OPG study]10.21596
GSM549123patient 088, normal, homogenized [OPG study]10.610396
GSM549124patient 006, cancer, homogenized [OPG study]9.527693
GSM549126patient 015, cancer, homogenized [OPG study]9.5614892
GSM549128patient 025, cancer, homogenized [OPG study]9.4598492
GSM549103patient 117, normal, homogenized [OPG study]10.066794
GSM549117patient 073, normal, homogenized [OPG study]11.042497
GSM549138patient 041, cancer, homogenized [OPG study]9.9207894
GSM549141patient 045, cancer, homogenized [OPG study]10.217595
GSM549130patient 028, cancer, homogenized [OPG study]9.7132193
GSM549101patient 111, normal, homogenized [OPG study]9.9054894
GSM549105patient 128, normal, homogenized [OPG study]9.7985993
GSM549106patient 134, normal, homogenized [OPG study]9.4607791
GSM549112patient 048, normal, homogenized [OPG study]10.632796
GSM549125patient 011, cancer, homogenized [OPG study]9.9074394
GSM549127patient 024, cancer, homogenized [OPG study]9.5921893
GSM549135patient 035, cancer, homogenized [OPG study]10.246795